Send feedback

CCT5 p.Ala437Val

c.1310C>T · rs149067488 · VCV575826

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.7933 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00466%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
hereditary sensory and autonomic neuropathy with spastic paraplegia

Computational evidence

Protein change
AlphaMissense0.7933likely pathogenic
REVEL0.848moderately pathogenic-leaning
SaProtLLR -13.90damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 4.9GERP 2.6, phastCons 1
Regional constrainto/e 0.69unconstrained · MANE · 7,066 bp · p 1.6e-09 · regional, not allelic
Overall
CADD25.4PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00466% European (non-Finnish) · 55/1,180,010 alleles
Filtering AF 0.00367% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00329%
Overall 0.00397% 64/1,614,020 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0048% 20,830
European (non-Finnish)grpmax 0.00466% 21,455
South Asian 0.00439% 22,772
East Asian 0.00223% 44,894
Admixed American 0.00167% 60,002

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CCT5
Protein
p.Ala437Val
Coding
c.1310C>T
MANE Select
NM_012073
dbSNP
rs149067488
Type
single nucleotide variant
Location
chr5:10262611 (GRCh38)
Gene constraint
LOEUF 0.235 · pLI 1.00 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 89.34 · 75 PDB
Residue 437
an α-helix
Full CCT5 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary sensory and autonomic neuropathy with spastic paraplegia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Mutilating hereditary sensory neuropathy with spastic paraplegia (Orphanet):

Inheritance
Autosomal recessive
Onset
Childhood, Infancy

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cct5-p-ala437val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown